Anacor Pharmaceuticals' P2P Acquisition

Anacor Pharmaceuticals raised a round of funding on May 16, 2016. Investors include Pfizer.

Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Anacor has focused initially o…

Articles about Anacor Pharmaceuticals' P2P Acquisition: